Profusa and Partners Announce DARPA-Backed Study to Measure Early Signs of Influenza Biodetection March 11, 2020 …
DARPA P3 Researchers Race to Create Treatment for the Novel Coronavirus Medical Countermeasures March 11, 2020 …
Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans February 10, 2020 …
AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program Medical Countermeasures January 29, 2020 …
Personalized Protective Biosystems: DARPA Program Developing Innovative Threat Barriers CBRNE January 2, 2020 …
Mount Sinai Receives U.S. Military Contract to Identify Exposure to Weaponized Infectious Agents Biodetection October 10, 2019 …
Inovio’s Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases Medical Countermeasures July 25, 2019 …
Army Researchers Explore Protective Filtration Benefits of Biologically-Templated Carbon Nanofiber (BioCNF) CBRNE June 17, 2019 …
DARPA Seeks First-in-Human Therapeutic Interfering Particles Targeting Respiratory Viruses Contracts + Grants May 27, 2019 …
AbCellera to Lead Development of Rapid Response Platform Against Pandemic Threats Contracts + Grants March 14, 2018 …
